These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 39223661)

  • 1. Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity-associated EAAT2.
    D'Ambrosio A; Zamboni S; Camerini S; Casella M; Sanchez M; Pietraforte D; Vanacore N; Diociauti M; Altieri M; Di Piero V; Francia A; Pontecorvo S; Puthenparampil M; Gallo P; Margutti P
    J Neuroinflammation; 2024 Sep; 21(1):217. PubMed ID: 39223661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.
    Mazzucco M; Mannheim W; Shetty SV; Linden JR
    Fluids Barriers CNS; 2022 Feb; 19(1):13. PubMed ID: 35135557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology.
    Cuomo-Haymour N; Bergamini G; Russo G; Kulic L; Knuesel I; Martin R; Huss A; Tumani H; Otto M; Pryce CR
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.
    Welton JL; Loveless S; Stone T; von Ruhland C; Robertson NP; Clayton A
    J Extracell Vesicles; 2017; 6(1):1369805. PubMed ID: 28959386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.
    Pieragostino D; Lanuti P; Cicalini I; Cufaro MC; Ciccocioppo F; Ronci M; Simeone P; Onofrj M; van der Pol E; Fontana A; Marchisio M; Del Boccio P
    J Proteomics; 2019 Jul; 204():103403. PubMed ID: 31170500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
    Teunissen CE; Koel-Simmelink MJ; Pham TV; Knol JC; Khalil M; Trentini A; Killestein J; Nielsen J; Vrenken H; Popescu V; Dijkstra CD; Jimenez CR
    Mult Scler; 2011 Jul; 17(7):838-50. PubMed ID: 21505015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics.
    Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G
    Front Immunol; 2021; 12():700031. PubMed ID: 34489947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
    J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.
    Guha D; Lorenz DR; Misra V; Chettimada S; Morgello S; Gabuzda D
    J Neuroinflammation; 2019 Dec; 16(1):254. PubMed ID: 31805958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
    Dekeyser C; Hautekeete M; Cambron M; Van Pesch V; Patti F; Kuhle J; Khoury S; Lechner Scott J; Gerlach O; Lugaresi A; Maimone D; Surcinelli A; Grammond P; Kalincik T; Habek M; Willekens B; Macdonell R; Lalive P; Csepany T; Butzkueven H; Boz C; Tomassini V; Foschi M; Sánchez-Menoyo JL; Altintas A; Mrabet S; Iuliano G; Sa MJ; Alroughani R; Karabudak R; Aguera-Morales E; Gray O; de Gans K; van der Walt A; McCombe PA; Deri N; Garber J; Al-Asmi A; Skibina O; Duquette P; Cartechini E; Spitaleri D; Gouider R; Soysal A; Van Hijfte L; Slee M; Amato MP; Buzzard K; Laureys G
    J Neurol Neurosurg Psychiatry; 2024 Oct; 95(11):1021-1031. PubMed ID: 38569872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
    Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
    J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Faces of "Too Late"-A Surprisingly Progressive Cohort of "Stable" Relapsing Remitting Multiple Sclerosis Patients.
    Ciubotaru A; Grosu C; Alexa D; Covali R; Maștaleru A; Leon MM; Schreiner TG; Ghiciuc CM; Roman EM; Azoicăi D; Ignat EB
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336442
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of Plasma Using Flow Cytometry Reveals Increased Immune Cell-Derived Extracellular Vesicles in Untreated Relapsing-Remitting Multiple Sclerosis.
    Blandford SN; Fudge NJ; Corkum CP; Moore CS
    Front Immunol; 2022; 13():803921. PubMed ID: 35392085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Size Exclusion Chromatography for Extracellular Vesicle Enrichment and Proteomic Analysis from Clinically Relevant Samples.
    Lane RE; Korbie D; Trau M; Hill MM
    Proteomics; 2019 Apr; 19(8):e1800156. PubMed ID: 30632691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.